Headlines
-
PPIs not linked with stomach cancer
Friday | Jan 23 2026THE long term use of proton pump inhibitors (PPIs), which treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric cancer, a large new study published in The BMJ has found.
-
TWC reveals future of prescribing
Thursday | Jan 22 2026TERRYWHITE Chemmart (TWC)has outlined its 2026 vision for what pharmacist prescribing looks like in practice, as full scope moves from pilot programs and early adoption to an embedded model of care.
-
iNova, CWH team up to recycle
Thursday | Jan 22 2026INOVA Pharmaceuticals is partnering with Chemist Warehouse and Pharmacycle to help reduce blister pack waste and encourage more sustainable healthcare practices.
-
Priceline hits back at reports
Wednesday | Jan 21 2026IN AN open letter to franchisees this week, Priceline Pharmacy's chief customer officer Richard Pearson has hit back at "inaccurate" media reports around Infinity's entry into administration last year.
-
Warnings over andrographis anaphylaxis
Wednesday | Jan 21 2026AN UPDATED safety review of herbal medicine ingredient Andrographis paniculata is currently underway, amid ongoing reports of anaphylaxis and other severe allergic reactions.
-
Mobile chat helps with quit smoking
Wednesday | Jan 21 2026FOR people who are trying to quit smoking, mobile chat messaging with a counsellor and a supportive chatbot app can help prevent relapse by as much as 30%, according to international research published today in JAMA Internal Medicine.
-
A new look for Blooms The Chemist
Tuesday | Jan 20 2026BLOOMS The Chemist has launched the banner's new retail brand concept, with its Figtree (NSW) pharmacy unveiled as the first in its network to undergo a refreshed store design as part of the strategy.
-
Tattoo inks affect immune system
Tuesday | Jan 20 2026TATTOOS are more than skin deep, with inks accumulating in large quantities in the lymph nodes within a few hours of needling, according to a new international study.
-
Adrenaline nasal spray TGA approved
Monday | Jan 19 2026CSL Seqirus has announced the listing of Neffy adrenaline (epinephrine) nasal spray on the Australian Register of Therapeutic Goods (ARTG), approved for the treatment of anaphylaxis in adults and children weighing 15kg or more, and aged four years and over.
-
Scaling lessons from lychee farming
Monday | Jan 19 2026QUEENSLAND-BASED pharmacist owner and entrepreneur Roy Packer shares his thoughts on the parallels between agricultural practices and pharmacy.
